Surgery Partners, Inc. (SGRY) intrinsic value & 10-year financials
Surgery Partners, Inc. (SGRY) has a Graham intrinsic value of $5.78 per share. At $14.61 on Oct 17, 2026, the stock trades 153% above that value. Over the last 10 fiscal years revenue grew 12.5% a year to $3.3B, with an average return on invested capital of 7.4%.
- Graham intrinsic value
- $5.78
- Share price (Oct 17, 2026)
- $14.61
- Price vs Graham value
- 153% above
- Market cap
- $1.9B
- Revenue (FY2025)
- $3.3B
- Revenue growth (10-yr CAGR)
- 12.5%
- ROIC (10-yr avg)
- 7.4%
- Free cash flow (FY2025)
- $195.6M
SGRY 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $3.3B | -$77.9M | -$0.61 | $195.6M | 11.8% | 7.7% |
| FY2024 | $3.1B | -$168.1M | -$1.33 | $209.7M | 11.2% | 7.4% |
| FY2023 | $2.7B | -$11.9M | -$0.09 | $205.0M | 12.0% | 7.2% |
| FY2022 | $2.5B | -$54.6M | -$0.59 | $78.2M | 13.6% | 8.7% |
| FY2021 | $2.2B | -$70.9M | -$1.12 | $29.5M | 13.6% | 9.6% |
| FY2020 | $1.9B | -$116.1M | -$3.19 | $204.0M | 9.8% | 5.7% |
| FY2019 | $1.8B | -$74.8M | -$2.29 | $55.9M | 12.9% | 8.8% |
| FY2018 | $1.8B | -$205.7M | -$4.96 | $104.8M | 4.4% | 3.0% |
| FY2017 | — | — | — | — | — | — |
| FY2016 | $1.1B | $9.5M | $0.20 | $86.1M | 17.2% | 8.1% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Surgery Partners, Inc. is a consistent compounder, expanding top-line revenue at 12.5% annually over the past decade.
Surgery Partners, Inc. has historically struggled to out-earn its cost of capital, averaging just 7.4% ROIC.
Over the decade, Surgery Partners, Inc. shows that the company has leveraged its balance sheet to sustain operations.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Surgery Partners, Inc. is modeled at 12.5% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $5.78 per share.